Kidney function in people taking long-term tenofovir for chronic hepatitis B
Looks at kidney function in adults with chronic hepatitis B taking tenofovir.
Plain-language title generated from the registry record
Registry title: Effect of Tenofovir (TDF) on Renal Function in Patients With Chronic Hepatitis B
Key facts
- Where
- Asyut, EgyptSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 60 years old?
Source: NCT06896630, who can take part
Where in Egypt
- Faculty of medicineAsyut, EgyptNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Assiut University
- Trial code
- NCT06896630
- Record updated
- 4 April 2025
- Original description
Effect of Long-Term Use of Tenofovir (TDF) on Renal Function in Patients with Chronic Hepatitis B Over a Five-Year PeriodRead full original descriptionShow less
Effect of Long-Term Use of Tenofovir (TDF) on Renal Function in Patients With Chronic Hepatitis B
Effect of Long-Term Use of Tenofovir (TDF) on Renal Function in Patients with Chronic Hepatitis B Over a Five-Year Period
Inclusion: Adult male or female patients aged 18 to 60 years; Diagnosed as HBV-positive; Long-term use of Tenofovir Disoproxil Fumarate (TDF) for more than five years.
Exclusion: Patients on combination therapy, including:; Interferon and Nucleoside analogue combination therapy; Multiple nucleoside analogue combination therapy; Presence of other chronic liver diseases; Diagnosed with Chronic Kidney Disease (CKD), regardless of etiology; Patients who refuse to participate in the study.